Results 221 to 230 of about 7,001,644 (259)
Some of the next articles are maybe not open access.

Measurement of disease progression in Alzheimer's disease

Neurobiology of Aging, 1988
Riege and Metter's comprehensive review deals with many issues pertaining to Alzheimer's disease research. We agree with the authors that early diagnosis and evaluation of disease progression represent key points that must be addressed in an integrated manner. Brain imaging holds great promise for the resolution of both issues.
R P, Friedland, B, Horwitz, E, Koss
openaire   +2 more sources

Gastroesophageal reflux disease is a progressive disease

Digestive and Liver Disease, 2007
It is controversial whether gastrooesophageal reflux disease represents a spectrum disease from a nonerosive to a complicated one, or whether it is a categorial disease, i.e. it can be divided into three categories, such as nonerosive gastrooesophageal reflux disease, erosive gastrooesophageal reflux disease and Barrett's esophagus (BE) with little or ...
F. Pace, S. Pallotta, N. Vakil
openaire   +3 more sources

Progress in Parkinson's Disease

New England Journal of Medicine, 1984
Over the past few years important advances have taken place in the study of Parkinson's disease.
openaire   +2 more sources

Progressive Shrinkage of Involved Arteries in Parallel with Disease Progression in Moyamoya Disease

World Neurosurgery, 2019
Recent three-dimensional constructive interference in steady state (3D-CISS) studies have shown that the involved arteries decrease not only their own luminal caliber but also outer diameter in moyamoya disease (MMD). This study was aimed to clarify how the outer diameter of the involved arteries serially change during disease progression in MMD using ...
Shusuke Yamamoto   +5 more
openaire   +2 more sources

Statins and progressive renal disease

Medicinal Research Reviews, 2001
AbstractThanks to the administration of hypocholesterolemic drugs, important advances have been made in the treatment of patients with progressive renal disease. In vitro and in vivo findings demonstrate that statins, the inhibitors of HMG‐CoA reductase, can provide protection against kidney diseases characterized by inflammation and/or enhanced ...
BUEMI, Michele   +8 more
openaire   +3 more sources

Factors for progression of periodontal diseases

Journal of Oral Pathology & Medicine, 1998
Progression factors for periodontal diseases have been suggested by in vitro study of peripheral blood and gingival cells; however, those factors are not established in vivo. This investigation assessed biopsies of three groups of gingival tissues: those adjacent to a 1) 3 mm (normal), 2) 4‐6 mm, and 3) <6 mm gingival sulcus, to determine changes in
S D, Ellis   +3 more
openaire   +2 more sources

The progression of Parkinson disease

Neurology, 2007
Recent neuropathologic studies suggest that Parkinson disease (PD) does not begin in the substantia nigra compacta (SNc) but only involves this region later in the course of the disease. It is proposed that once the SNc is affected by the original pathobiological process (for example, protein aggregation), additional processes more specific to ...
openaire   +2 more sources

Characteristics of progressive renal disease

Clinica Chimica Acta, 2000
Virtually all renal diseases progress to terminal renal failure relatively independently of the initial disease. Arresting the rate of the deterioration of kidney failure has a great impact on reducing the number of patients reaching the stage of expensive renal replacement therapy.
M, Ots, U, Pechter, A, Tamm
openaire   +2 more sources

Pharmacoepigenomics in Neurodegenerative Diseases

Medical Epigenetics, 2021
Nicoletta Nuzziello, Maria Liguori
exaly  

Environmental Epigenetic Epidemiology

Medical Epigenetics, 2021
Alexander Koliada   +2 more
exaly  

Home - About - Disclaimer - Privacy